Literature DB >> 27381669

Reliability of the Size Evaluation Method for Meningiomas: Maximum Diameter, ABC/2 Formula, and Planimetry Method.

Yukitomo Ishi1, Shunsuke Terasaka1, Shigeru Yamaguchi2, Michiharu Yoshida1, Shogo Endo1, Hiroyuki Kobayashi1, Kiyohiro Houkin1.   

Abstract

BACKGROUND: To evaluate the accuracy of tumor size by maximum diameter, ABC/2 formula, and planimetry method using thick-slice and thin-slice magnetic resonance imaging (MRI).
METHODS: Maximum diameter and tumor volume calculated using ABC/2 formula (V1) and planimetry method with thick-slice MRI (V2) and thin-slice MRI (V3) were examined in 83 meningiomas. Form factor (FF) analysis was performed to assess irregularity of the tumor. V3 values were considered as real tumor volumes. The accuracy of V1 and V2 was evaluated using ratio and difference from V3. Meningiomas were categorized by tumor locations: skull base (anterior, middle, and posterior) and non-skull base (calvaria and other sites).
RESULTS: Correlation between maximum diameter and V3 was statistically significant (r = 0.91), but the error was significant in tumors with longer maximum diameters. Correlation between V1 and V3 was significant (r = 0.97). However, V1 tended to be larger in middle skull base meningiomas or in tumors with low FF values (R2 = 0.21). V2 represented relatively accurate volumes in both groups except in the case of small meningiomas. When tumors were demonstrated within 3 fractions on thick-slice MRI, the ratio of V2 to V3 showed significant variability.
CONCLUSIONS: Using the ABC/2 formula, the volume of meningiomas in the middle skull base or meningiomas with low FF value might be calculated larger than the real tumor volume. The planimetry method with thick-slice MRI demonstrated relatively accurate volumes if the tumor was fractionated in >4 slices.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ABC/2 formula; Maximum diameter; Meningioma; Planimetry method; Volumetric analysis

Mesh:

Year:  2016        PMID: 27381669     DOI: 10.1016/j.wneu.2016.06.108

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  6 in total

1.  Incidence, Clinico-Radiological Features and Outcome of Skull Base versus Non-Skull Base Meningiomas Treated in Kuala Lumpur General Hospital: A Five-Year Experience.

Authors:  Chan Chee Kong; Regunath Kandasamy; Saffari Haspani; Zamzuri Idris; Jafri Malin Abdullah
Journal:  Malays J Med Sci       Date:  2018-06-28

2.  Natural History of Meningiomas: Review with Meta-analyses.

Authors:  Satoshi Nakasu; Yoko Nakasu
Journal:  Neurol Med Chir (Tokyo)       Date:  2020-01-31       Impact factor: 1.742

3.  Clinical Outcome of Cytoreductive Surgery Prior to Bevacizumab for Patients with Recurrent Glioblastoma: A Single-center Retrospective Analysis.

Authors:  Shigeru Yamaguchi; Hiroaki Motegi; Yukitomo Ishi; Michinari Okamoto; Ryosuke Sawaya; Hiroyuki Kobayashi; Shunsuke Terasaka; Kiyohiro Houkin
Journal:  Neurol Med Chir (Tokyo)       Date:  2021-03-04       Impact factor: 1.742

4.  Simplifying Tumor Volume Estimation from Linear Dimensions for Intra-Cranial Lesions Treated with Stereotactic Radiosurgery.

Authors:  Sakshi Singhal; Maneet Gill; Chinmaya Srivastava; Darpan Gupta; Ashok Kumar; Aruna Kaushik; Manoj Kumar Semwal
Journal:  J Med Phys       Date:  2021-02-02

5.  Simple Ways to Estimate Meningioma Volume: Can ABC- and SH-Derived Methods Be Used in Clinical Practice Reliably?

Authors:  Dongdong Xiao; Jun Liu; Tingting Hu; Burkutally Mohammad Shah Nayaz; Xiaobing Jiang; Fangcheng Zhang; Pengfei Yan
Journal:  J Oncol       Date:  2021-08-23       Impact factor: 4.375

6.  The growth rate and clinical outcomes of radiation induced meningioma undergoing treatment or active monitoring.

Authors:  Conor S Gillespie; Abdurrahman I Islim; Basel A Taweel; Christopher P Millward; Siddhant Kumar; Nitika Rathi; Shaveta Mehta; Brian J Haylock; Nicola Thorp; Catherine E Gilkes; David D A Lawson; Samantha J Mills; Emmanuel Chavredakis; Jibril Osman Farah; Andrew R Brodbelt; Michael D Jenkinson
Journal:  J Neurooncol       Date:  2021-04-22       Impact factor: 4.130

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.